The Need for Multiple Sclerosis Research
Multiple sclerosis (MS) is a chronic disease of the central nervous system. Onset typically occurs between the ages of 20 and 40 years. Evidence suggests that MS is an autoimmune disease that causes inflammation and damage in the central nervous system. MS is the most common disabling neurological disease of young adults, and limited approved MS therapies are currently available.
How to Participate in a Multiple Sclerosis Clinical Trial
Velocity has research sites nationwide that are conducting clinical trials in a wide range of therapeutic areas. New studies are added every week. You can help fight MS by joining a clinical trial at Velocity.
Beyond helping advance medicine, you may also:
- Learn about potential new medicines in development
- Get study-related medical exams at no cost
- Receive compensation for participating (available amounts may differ for each study)
The best way to find out which MS research studies are currently enrolling patients in your community and determine your eligibility is to complete the form on this page or call Velocity to speak with an enrollment specialist.
After you submit your information, a Velocity enrollment specialist will contact you. Together, we’ll review studies that might be right for you and answer your questions.
Health insurance is NOT required to join. There is never an obligation to participate — we’re here to help you make the best decision.
For more information about currently enrolling multiple sclerosis clinical trials, complete the form on this page or select a location below to get in touch with a Velocity enrollment specialist.
